Poetry
Brainstorm Cell Therapeutics Inc (BCLI) Q2 2024 Earnings Call Transcript Highlights: Significant Reduction in Net Loss and Strategic Advancements
Cash, Cash Equivalents, and Restricted Cash: $3.65 million as of June 30, 2024, compared to $0.75 million as of June 30, 2023.Research and Development Expenses